Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC Capital analyst Gerard Cassidy maintains KeyCorp (NYSE:KEY) with a Outperform and raises the price target from $15 to $16.
Argus Research analyst Stephen Biggar maintains KeyCorp (NYSE:KEY) with a Buy and raises the price target from $15 to $16.
Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the la...
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
KeyCorp (NYSE:KEY) reported quarterly Adj earnings of $0.22 per share which met the analyst consensus estimate. This is a 26.67...
Cautious optimism hangs in the air on Thursday morning as index futures traded up moderately in early hours.
KeyCorp (NYSE:KEY) reported quarterly sales of $1.53 billion which beat the analyst consensus estimate of $1.51 billion by 1.52...
